Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STROgHAT: Acoziborole for gHAT Seropositives
NCT07789743Phase 3Recruiting
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of acoziborole in African trypanosomiasis (HAT), sponsored by Institute of Tropical Medicine Antwerp. Started Mar 2024; status: recruiting.
02
Drugs
acoziborole
03
Conditions
African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT07789743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07789743.